Terns Pharmaceuticals, Inc. (TERN) Financials
Stock symbol TERN is outdated, potentially delisted? Maybe it is available on other exchange?
TERN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 1.0 billion | 18.6 million |
| Sept. 30, 2025 | 301.7 million | 17.6 million |
| June 30, 2025 | 320.4 million | 15.2 million |
| March 31, 2025 | 339.3 million | 13.3 million |
TERN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -19.1 million | 3.4 million |
| Sept. 30, 2025 | -19.8 million | 3.3 million |
| June 30, 2025 | -18.9 million | 3.0 million |
| March 31, 2025 | -24.4 million | 3.7 million |
TERN Net Income
No data available :(
TERN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 1.0 billion | - | 919000 |
| Sept. 30, 2025 | 295.6 million | - | 1.0 million |
| June 30, 2025 | 315.4 million | - | 1.1 million |
| March 31, 2025 | 334.3 million | - | 1.2 million |
TERN Shares Outstanding
TERN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 18.9 million | 8.7 million | - |
| Sept. 30, 2025 | - | 19.9 million | 7.8 million | - |
| June 30, 2025 | - | 20.4 million | 7.0 million | - |
| March 31, 2025 | - | 18.7 million | 8.7 million | - |
TERN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | - | -108000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 108000 |
| March 31, 2025 | - | - |
TERN
Price: $52.95
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 59800
Market Capitalization: 6.1 billion